Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study - Beigel, J H; Voell, J; Kumar, P (Lancet Infect Dis, 2018)